Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A single-blinded randomized, placebo-controlled, staggered-parallel, escalating-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in Subjects with type 2 Diabetes Mellitus
albiglutide
GLP106073
NCT00354536
Diabetes Mellitus, Type 2
Phase 2
 
June 2014

Powered by ideaPoint, Inc.